First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.227 USD -3.81% Market Closed
Updated: May 21, 2024

Sonoma Pharmaceuticals Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sonoma Pharmaceuticals Inc
Net Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Net Income
-$5.1m
CAGR 3-Years
-45%
CAGR 5-Years
18%
CAGR 10-Years
2%
Johnson & Johnson
NYSE:JNJ
Net Income
$38.5B
CAGR 3-Years
37%
CAGR 5-Years
21%
CAGR 10-Years
10%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income
-$6.1B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income
-$275m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income
$2.3B
CAGR 3-Years
-20%
CAGR 5-Years
-23%
CAGR 10-Years
-7%
Eli Lilly and Co
NYSE:LLY
Net Income
$6.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
5%

See Also

What is Sonoma Pharmaceuticals Inc's Net Income?
Net Income
-5.1m USD

Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Net Income amounts to -5.1m USD.

What is Sonoma Pharmaceuticals Inc's Net Income growth rate?
Net Income CAGR 10Y
2%

Over the last year, the Net Income growth was 25%. The average annual Net Income growth rates for Sonoma Pharmaceuticals Inc have been -45% over the past three years , 18% over the past five years , and 2% over the past ten years .